130 Participants Needed

QuickSee Plus for Refractive Errors

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: PlenOptika, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

At the New England College of Optometry in Boston, MA, subjects ages 18-65 who have received or are receiving treatment for refractive error who choose to enroll in the study will be evaluated using subjective refraction and automated refraction, by way of the QuickSee Plus refractor. Subjects will then be randomized into one of two treatment plans: receive glasses from automated refraction first then subjective refraction second, and vice versa. After one week of wearing the first pair of glasses, patient preferences are assessed, and glasses are switched. After a week of wearing the second pair of glasses from the alternate measurement method, patient preferences are again assessed. Patients may then decide which pair patient like best. This is a triple blind, case-crossover clinical trial.

Are You a Good Fit for This Trial?

This trial is for individuals aged 18-65 who are currently being treated for refractive errors (vision problems) and are interested in finding the most comfortable eyeglass prescription. Participants will be evaluated at the New England College of Optometry in Boston, MA.

Inclusion Criteria

Patients who have had an eye exam at the NECO Center for Eye Care of Commonwealth or Roslindale

Exclusion Criteria

Patients whose refractive error is outside of the detection range of the QuickSee Free Pro and QuickSee Plus devices: -13 D to +10 D (S) and -8 D to + 8 D (C)
I am unable to give consent myself.
Patients wearing more than one pair of single vision eyeglasses for distance
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants are randomized to receive eyeglasses from either automated or subjective refraction first, followed by the alternate method

2 weeks
2 visits (in-person)

Follow-up

Participants are monitored for patient preference after wearing each pair of glasses

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • QuickSee Plus
Trial Overview The study tests the accuracy of QuickSee Plus, an automated device for assessing refractive error, against traditional subjective refraction methods. Participants will receive two pairs of glasses based on these methods and report which they prefer after wearing each pair for a week.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: SR Eyeglasses, then AR EyeglassesExperimental Treatment1 Intervention
Group II: AR Eyeglasses, then SR EyeglassesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

PlenOptika, Inc.

Lead Sponsor

Trials
2
Recruited
530+

New England College of Optometry

Collaborator

Trials
11
Recruited
13,100+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security